EE200600044A - Antisens-oligonukleotiid ja selle kasutamine perifeerse neuronaalse lmmastikoksiidi sntaasi allareguleerimiseks ning farmatseutiline kompositsioon - Google Patents
Antisens-oligonukleotiid ja selle kasutamine perifeerse neuronaalse lmmastikoksiidi sntaasi allareguleerimiseks ning farmatseutiline kompositsioonInfo
- Publication number
- EE200600044A EE200600044A EEP200600044A EEP200600044A EE200600044A EE 200600044 A EE200600044 A EE 200600044A EE P200600044 A EEP200600044 A EE P200600044A EE P200600044 A EEP200600044 A EE P200600044A EE 200600044 A EE200600044 A EE 200600044A
- Authority
- EE
- Estonia
- Prior art keywords
- sase
- regulation
- pharmaceutical composition
- nitric oxide
- antisense oligonucleotide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EEP200600044A EE200600044A (et) | 2006-12-29 | 2006-12-29 | Antisens-oligonukleotiid ja selle kasutamine perifeerse neuronaalse lmmastikoksiidi sntaasi allareguleerimiseks ning farmatseutiline kompositsioon |
PCT/EE2007/000026 WO2008080413A2 (en) | 2006-12-29 | 2007-12-21 | An antisense oligonucleotide, pharmaceutical composition and a method for downregulation of peripheral neuronal nitric oxide synthase and mu-opioid receptors and use of an antisense oligonucleotide for drug production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EEP200600044A EE200600044A (et) | 2006-12-29 | 2006-12-29 | Antisens-oligonukleotiid ja selle kasutamine perifeerse neuronaalse lmmastikoksiidi sntaasi allareguleerimiseks ning farmatseutiline kompositsioon |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200600044A true EE200600044A (et) | 2008-12-15 |
Family
ID=39199385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200600044A EE200600044A (et) | 2006-12-29 | 2006-12-29 | Antisens-oligonukleotiid ja selle kasutamine perifeerse neuronaalse lmmastikoksiidi sntaasi allareguleerimiseks ning farmatseutiline kompositsioon |
Country Status (2)
Country | Link |
---|---|
EE (1) | EE200600044A (et) |
WO (1) | WO2008080413A2 (et) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001087285A2 (en) * | 2000-05-12 | 2001-11-22 | The Johns Hopkins University | Inhibition of the interaction of psd93 and psd95 with the nnos and nmda receptors |
ES2696598T3 (es) * | 2005-03-21 | 2019-01-17 | Univ Columbia | Compuestos de balanol para su uso en el tratamiento de dolor |
-
2006
- 2006-12-29 EE EEP200600044A patent/EE200600044A/et unknown
-
2007
- 2007-12-21 WO PCT/EE2007/000026 patent/WO2008080413A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008080413A3 (en) | 2008-09-12 |
WO2008080413A2 (en) | 2008-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL195947A (en) | Manicured cyclic compounds and pharmaceutical preparations containing them for use @ for prevention @ and treatment @ for diabetes | |
EP2913327C0 (fr) | Bleu de méthylène et son utilisation médicale | |
CR10699A (es) | Antagonistas de wnt y su uso en el diagnostico y tratamiento de trastornos mediados por wnt | |
IL225198A (en) | Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes | |
EP2170360A4 (en) | VEGETABLE COMPOSITIONS FOR THE TREATMENT OF DIABETES AND / OR DISEASES IN CONNECTION WITH THIS | |
IL195906A0 (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
EP2056106A4 (en) | SUGAR CHAIN INFLUENCE SUBSTANCE AND ITS USE | |
EP2070540A4 (en) | DRUG COMPOSITION FOR THE TREATMENT OF DIABETES TYPE 2 AND CHRONIC NEOPATHY | |
EP1991218A4 (en) | USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES | |
IL193936A0 (en) | Compositions and methods for the treatment of immunoinflammatory disorders | |
GB0619860D0 (en) | Treatment of insulin resistance and disorders associated therewith | |
PL2066408T3 (pl) | Kompozycja na bazie ksantoksyliny i jej zastosowanie w kosmetyce | |
EP2056857A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH CCL2 AND THEIR USE IN THE TREATMENT OF INFLAMMATION | |
EP1954800A4 (en) | COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE | |
EP2004216A4 (en) | AGENT FOR THE TREATMENT OF HORMONO-DEPENDENT DISORDERS AND USES THEREOF | |
PL2012805T3 (pl) | Kompozycja lecznicza i jej zastosowanie | |
EP1928247A4 (en) | COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE | |
HK1134032A1 (en) | New combination for use in the treatment of inflammatory disorders | |
EP2029132A4 (en) | ANTIHISTAMINE COMPOSITIONS AND THEIR USE | |
GB0614365D0 (en) | Pharmaceutical compositions and their use | |
ZA201005875B (en) | Use of interleukin-1 conjugates in the treatment of diabetes | |
IL198134A (en) | A combination of antipsychotic drugs and tetracyclines to treat psychiatric illnesses | |
IL211267A (en) | Oxadiazole derivatives and drugs and their use in the treatment of diabetes | |
IL193943A0 (en) | The use of beta- aminoalcohols for the treatment of inflammatory disorders and pain | |
GB0620695D0 (en) | Composition and methods for the treatment of nurdegenerative disease |